Skip to content

The Study of Nutrition of Children and Adolescents With GERD

The Study of Nutrition of Children and Adolescents With GERD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04202276
Enrollment
219
Registered
2019-12-17
Start date
2017-01-01
Completion date
2021-12-31
Last updated
2022-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD, GERD in Children

Keywords

gastroesophageal reflux, weight, obesity, nutrition, GERD, esophageal pH-impedance, food frequency questionnair

Brief summary

This trial is to study the aspects of nutrition in children and adolescents with GERD compared to the sex and age-matched control group

Detailed description

The aim of the study is to assess the differences in nutrition of pediatric patients with GERD compared to the control group. The secondary aim is to study possible associations of the data on nutritional habits revealed with the use of food frequency questionnaire (FFQ) and the data of 24-hours oesophageal pH-impedance examination.

Interventions

Food frequency questionnaire to investigate differences in diet of children and adolescents with GERD compared to the age- and sex matched control group.

Sponsors

Federal State Budgetary Scientific Institution Federal Research Centre of Nutrition, Biotechnology
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Willingness to participate (written informed consent and consent from parents or legal representative according to the local law); * Age 6 to 17 years old inclusive, * Possibility to assess symptoms, data of the medical history and receive answers to the questions about usual diet.

Exclusion criteria

* history of abdominal surgery; * presence of varicose veins of the stomach and/or the oesophagus either in medical history or found during the study; * inability to tolerate at least one of the invasive procedures or lacking data of the other instrumental examinations required by protocol; * general condition of the patient making impossible to perform all the examinations or when performing the procedures is not safe and reasonable based on the opinion of the investigator that it may exacerbate the disease flow or put the patient at risk; * intake of medications which may influence the clinical and instrumental data, including, but not limited to: non-steroid anti-inflammatory agents, glucocorticosteroids (except for skin products, if they were used for 2 weeks or less at the time of inclusion into the study), medications affecting adrenergic, acetylcholine receptors, antidepressants, tranquillizers, sedatives, those with known local irritant effect on the gastrointestinal tract mucosa; the use of proton pump inhibitors and H2 receptors blockers are not allowed during the study, a wash-out period for at least 2 weeks is necessary before the enrolment.

Design outcomes

Primary

MeasureTime frameDescription
Dietary fibre consumptionAn average of 1 yearvalue of mean daily consumption of dietary fibre, by food frequency questionnaire, G/day
Energy value of the rationAn average of 1 yearvalue of mean daily consumption of the energy by food frequency questionnaire, kcal/day
total fat consumptionAn average of 1 yearvalue of mean daily consumption of fats by food frequency questionnaire, G/day
total carbohydrate consumptionAn average of 1 yearvalue of mean daily consumption of carbohydrates, by food frequency questionnaire, G/day
total protein consumptionAn average of 1 yearvalue of mean daily consumption of protein by food frequency questionnaire, G/day

Secondary

MeasureTime frameDescription
Total number of gastroesophageal refluxes24-hoursThis measure is to be obtained by 24-hours oesophageal pH-impedance study
Number of acid gastroesophageal refluxes24-hoursThis measure is to be obtained by 24-hours oesophageal pH-impedance study
Number of weak-acid gastroesophageal refluxes24-hoursThis measure is to be obtained by 24-hours oesophageal pH-impedance study
Number of high gastroesophageal refluxes24-hoursThis measure is to be obtained by 24-hours oesophageal pH-impedance study
Acid exposure time24-hoursThis measure is to be obtained by 24-hours oesophageal pH-impedance study

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026